The natural history of tardive dystonia. A long-term follow-up study of 107 cases

Brain

Volumn 121, Issue 11, 1998, Pages 2053-2066

  Kiriakakis, Vassilios ^a   Bhatia, Kailash P ^a   Quinn, Niall P ^a   Marsden, C David ^a  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

Dopamine antagonists; Dystonia; Movement disorder; Neuroleptics; Tardive

Indexed keywords

BENZODIAZEPINE DERIVATIVE; BOTULINUM TOXIN; CLOZAPINE; DOPAMINE RECEPTOR BLOCKING AGENT; NEUROLEPTIC AGENT;

ADULT; ARTICLE; CLINICAL FEATURE; DISEASE COURSE; DYSTONIA; FACE; FEMALE; FOLLOW UP; GENETIC PREDISPOSITION; HISTORY; HUMAN; IDIOPATHIC DISEASE; LEG; MAJOR CLINICAL STUDY; MALE; MENTAL DISEASE; ONSET AGE; PRIORITY JOURNAL; REMISSION; RISK FACTOR; SCHIZOPHRENIA; TORTICOLLIS;

ADOLESCENT; ADULT; AGE FACTORS; AGE OF ONSET; AGED; ANTIPSYCHOTIC AGENTS; DYSKINESIA, DRUG-INDUCED; DYSTONIA; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MENTAL DISORDERS; MIDDLE AGED; RECURRENCE; REMISSION, SPONTANEOUS; RISK FACTORS; TIME FACTORS;

EID: 0031789919     PISSN: 00068950     EISSN: None     Source Type: Journal    
DOI: 10.1093/brain/121.11.2053     Document Type: Article

References (88)

1. Adityanjee, Estrera AB. Successful treatment of tardive dystonia with clozapine [letter]. Biol Psychiatry 1996; 39: 1064-5.
2. Angermeyer MC, Kuhn L. Gender differences in age at onset of schizophrenia: an overview [Review]. Eur Arch Psychiatry Neurol Sci 1988; 237: 351-64.
3. Bartels M, Themelis J. Computerized tomography in tardive dyskinesia: evidence of structural abnormalities in the basal ganglia system. Arch Psychiatry Nervenkr 1983; 233: 371-9.
4. Bartzokis G, Garber HJ, Marder SR, Olendorf WH. MRI in tardive dyskinesia: shortened left caudate T2. Biol Psychiatry 1990; 28: 1027-36.
5. Benes FM, Paskevich PA, Davidson J, Domesick VB. The effects of haloperidol on synaptic patterns in the rat striatum. Brain Res 1985; 329: 265-73.
6. Ben-Shachar D, Livne E, Spanier I, Leenders KL, Youdim MB. Typical and atypical neuroleptics induce alteration in blood-brain barrier and brain 59FeCl3 uptake. J Neurochem 1994; 62: 1112-8.
7. Bhatia KP, Quinn NP, Marsden CD. Clinical features and natural history of axial predominant adult onset primary dystonia. J Neurol Neurosurg Psychiatry 1997; 63: 788-91.
8. Borg DC, Cotzias GC. Interaction of trace metals with phenothiazine drug derivatives. II. Formation of free radicals. Proc Natl Acad Sci USA 1962; 48: 623-42.
9. Bressman SB, De Leon D, Raymond D, Greene PE, Brin MF, Fahn S, et al. Secondary dystonia and the DYT1 gene. Neurology 1997; 48: 1571-7.
10. Burke RE, Fahn S, Jankovic J, Marsden CD, Lang AE, Gollomp S, et al. Tardive dystonia: late-onset and persistent dystonia caused by antipsychotic drugs. Neurology 1982; 32: 1335-46.
11. Cadet JL, Lohr JB. Possible involvement of free radicals in neuroleptic-induced movement disorders: evidence from treatment of tardive dyskinesia with vitamin E. [Review]. Ann NY Acad Sci 1989; 570: 176-85.
12. Campbell WG, Raskind MA, Gordon T, Shaw CM, Iron pigment in the brain of a man with tardive dyskinesia. Am J Psychiatry 1985; 142: 362-5.
13. Casey DE. Affective disorders and tardive dyskinesia. [Review]. Encephale 1988; 14 Spec No: 221-6.
14. Channon RA. Schizophrenia. In: Flaherty JA, Davis JM, Janicak PG, editors. Psychiatry: diagnosis and therapy. Norwalk (CT): Appleton and Lange; 1993. p, 91-120.
15. Chateau R, Fau R, Groslambert R, Perret J. Apropos of a case of irreversible spasmodic torticollis occurring during treatment by neuroleptics. [French]. Rev Neurol (Paris)1966; 114: 65-8.
16. Chiu H, Shum P, Lau J, Lam L, Lee S. Prevalence of tardive dyskinesia, tardive dystonia, and respiratory dyskinesia among Chinese psychiatric patients in Hong Kong. Am J Psychiatry 1992; 149: 1081-5.
17. Christensen E, Moller JE, Faurbye A. Neuropathological investigation of 28 brains from patients with dyskinesia. Acta Psychiatr Scand 1970; 46: 14-23.
18. Comaty JE Movement disorders. In: Flaherty JA, Davis JM, Janicak PG, editors. Psychiatry: diagnosis and therapy. Norwalk (CT): Appleton and Lange; 1993. p. 449-63.
19. Dabiri LM, Pasta D, Darby JK, Mosbacher D. Effectiveness of vitamin E for treatment of long-term tardive dyskinesia. Am J Psychiatry 1994; 151: 925-6.
20. Davis KL, Berger PA, Hollister LE, Tardive dyskinesia and depressive illness. Psychopharmacol Commun 1976; 2: 125-30.
21. Decsi L, Further studies on the metabolic background of tranquilizing drug action. Psychopharmacologia 1961; 2: 224-42.
22. Egan MF, Hyde TM, Albers GW, Elkashef A, Alexander RC, Reeve A, et al. Treatment of tardive dyskinesia with vitamin E [see comments]. Am J Psychiatry 1992; 149: 773-7. Comment in: Am J Psychiatry 1993; 150: 991-3.
23. Egan MF, Hyde TM, Albers GW, Elkashef A, Alexander RC, Reeve A, et al. Treatment of tardive dyskinesia with vitamin E [see comments]. Am J Psychiatry 1992; 149: 773-7. Comment in: Am J Psychiatry 1993; 150: 991-3.
24. Elkashef AM, Ruskin PE, Bacher N, Barrett D. Vitamin E in the treatment of tardive dyskinesia [see comments]. Am J Psychiatry 1990; 147: 505-6. Comment in: Am J Psychiatry 1991; 148: 279.
25. Elkashef AM, Ruskin PE, Bacher N, Barrett D. Vitamin E in the treatment of tardive dyskinesia [see comments]. Am J Psychiatry 1990; 147: 505-6. Comment in: Am J Psychiatry 1991; 148: 279.
26. Factor SA, Matthews MK. Persistent extrapyramidal syndrome with dystonia and rigidity caused by combined metoclopramide and prochlorperazine therapy. South Med J 1991; 84: 626-8.
27. Fletcher NA, Harding AE, Marsden CD. A genetic study of idiopathic torsion dystonia in the United Kingdom. Brain 1990; 113: 379-95.
28. Fletcher NA, Harding AE, Marsden CD. The relationship between trauma and idiopathic torsion dystonia. J Neurol Neurosurg Psychiatry 1991; 54: 713-7.
29. Friedman JH. Clozapine treatment of psychosis in patients with tardive dystonia: report of three cases. Mov Disord 1994; 9: 321-4.
30. Friedman JH, Kucharski LT, Wagner RL. Tardive dystonia in a psychiatric hospital. J Neurol Neurosurg Psychiatry 1987; 50: 801-3.
31. Gabellini AS, Pezzoli A, De Massig P, Sacquegna T, Veralipride-induced tardive dystonia in a patient with bipolar psychosis. Ital J Neurol Sci 1992; 13: 621-3.
32. Gardos G, Cole JO, Salomon M, Schniebolk S. Clinical forms of severe tardive dyskinesia. Am J Psychiatry 1987a; 144: 895-902.
33. Gardos G, Cole JO, Schniebolk S, Salomon M. Comparison of severe and mild tardive dyskinesia: implications for etiology. J Clin Psychiatry 1987b; 48: 359-62.
34. Gimenez-Roldan S, Mateo D, Bartolome P. Tardive dystonia and severe tardive dyskinesia. A comparison of risk factors and prognosis. Acta Psychiatr Scand 1985; 71: 488-94.
35. Guala A, Mittino D, Ghini T, Quazza G. Are metoclopramide dystonias familial? [Italian]. Pediatr Med Chir 1992; 14: 617-8.
36. Gureje O. The significance of subtyping tardive dyskinesia: a study of prevalence and associated factors. Psychol Med 1989; 19: 121-8.
37. Halliwell B, Gutteridge JMC. Free radicals in biology and medicine. 2nd ed. Oxford: Clarendon Press 1989.
38. Hare EH. Epidemiology of schizophrenia and affective psychoses. [Review]. Br Med Bull 1987; 43: 514-30.
39. Hunter R, Blackwood W, Smith MC, Cumings JN. Neuropathological findings in three cases of persistent dyskinesia following phenothiazine medication, J Neurol Sci 1968; 7: 263-73.
40. Inada T, Yagi G, Kaijima K, Ohnishi K, Kamisada M, Rockhold RW. Clinical variants of tardive dyskinesia in Japan. Jpn J Psychiatry Neurol 1991; 45: 67-71.
41. Jellinger K. Neuropathologic findings after neuroleptic long-term therapy. In: Roizin L, Shiraki H, Grêevic N, editors. Neurotoxicology. New York: Raven Press; 1977. p. 25-41.
42. Kang UJ, Burke RE, Fahn S. Natural history and treatment of tardive dystonia. Mov Disord 1986; 1: 193-208.
43. Kaufman MA. Alternative diagnosis to tardive dyskinesia: Neuropathologic findings in three suspected cases. In: Roizin L, Shiraki H, Grêevic N, editors. Neurotoxicology. New York: Raven Press; 1977.
44. Keegan DL, Rajput AH. Drug induced dystonia tarda: treatment with L-dopa. Dis Nerv Syst 1973; 34: 167-9.
45. Kiriakakis V, Bhatia K, Quinn NP, Marsden CD. Botulinum toxin treatment of tardive syndromes [abstract]. Movement Disorders 1997; 12: 27.
46. Lamberti JS, Bellnier T, Clozapine and tardive dystonia. J Nerv Ment Dis 1993; 181: 137-8.
47. Lieberman JA, Saltz BL, Johns CA, Pollack S, Borenstein M, Kane J, The effects of clozapine on tardive dyskinesia. Br J Psychiatry 1991; 158: 503-10.
48. Lohr JB. Oxygen radicals and neuropsychiatric illness-some speculations. Arch Gen Psychiatry 1991; 48: 1097-106.
49. Lohr JB, Cadet JL, Lohr MA, Jeste DV, Wyatt RJ. α-Tocopherol in tardive dyskinesia [letter]. Lancet 1987; 1: 913-4.
50. Lohr JB, Cadet JL, Lohr MA, Larson L, Wash E, Wade L, et al. Vitamin E in the treatment of tardive dyskinesia: the possible involvement of free radical mechanisms. Schizophr Bull 1988; 14: 291-6.
51. Loranger AW. Sex difference in age at onset of schizophrenia. Arch Gen Psychiatry 1984; 41: 157-61.
52. Micheli F, Fernandez Pardal M, Gatto M, Asconape J, Giannaula R, Parera IC. Bruxism secondary to chronic antidopaminergic drug exposure. Clin Neuropharmacol 1993; 16: 315-23.
53. Miller LG, Jankovic J. Metoclopramide-induced movement disorders. Clinical findings with a review of the literature. [Review]. Arch Intern Med 1989; 149: 2486-92.
54. Miller LG, Jankovic J. Sulpiride-induced tardive dystonia. Mov Disord 1990; 5: 83-4.
55. Mion CC, Andreasen NC, Arndt S, Swayze VW 2d, Cohen GA. MRI abnormalities in tardive dyskinesia. Psychiatry Res 1991; 40: 157-66.
56. Mukherjee S, Rosen AM, Caracci G, Shukla S. Persistent tardive dyskinesia in bipolar patients. Arch Gen Psychiatry 1986; 43: 342-46.
57. Nielsen EB, Lyon M. Evidence for cell loss in corpus striatum after long-term treatment with a neuroleptic drug (flupenithixol) in rats. Psychopharmacology (Berlin) 1978; 59: 85-9.
58. Nutt JG, Muenter MD, Aronson A, Kurland LT, Melton LJ 3d. Epidemiology of focal and generalized dystonia in Rochester, Minnesota. Mov Disord 1988; 3: 188-94.
59. Pahl JJ, Mazziotta JC, Bartzokis G, Cummings J, Altschuler L, Mintz J, et al. Positron-emission tomography in tardive dyskinesia. J Neuropsychiatry Clin Neurosci 1995; 7: 457-65.
60. Pall HS, Williams AC, Blake DR, Lunec J. Evidence of enhanced lipid peroxidation in the cerebrospinal fluid of patients taking phenothiazines. Lancet 1987; 2: 596-9.
61. Fourcher E, Baruch P, Bouchard RH, Filteau MJ, Bergeron D. Neuroleptic associated tardive dyskinesias in young people with psychoses [see comments]. Br J Psychiatry 1995; 166: 768-72. Comment in: Br J Psychiatry 1995; 167: 410-1.
62. Fourcher E, Baruch P, Bouchard RH, Filteau MJ, Bergeron D. Neuroleptic associated tardive dyskinesias in young people with psychoses [see comments]. Br J Psychiatry 1995; 166: 768-72. Comment in: Br J Psychiatry 1995; 167: 410-1.
63. Raja M. Tardive dystonia: prevalence, risk factors, and comparison with tardive dyskinesia in a population of 200 acute psychiatric inpatients. Eur Arch Psychiatry Clin Neurosci 1995; 245: 145-51.
64. Rajan KS, Manian AA, Davis JM, Skripkus A. Studies on metal chelation of chlorpromazine and its hydroxylated metabolites. In: Forrest IS, Carr CJ, Usdin E, editors. Phenothiazines and sructurally related drugs. New York: Raven Press; 1974. p. 571-92.
65. Richter D. Mode of action of the phenothiazines. In: Marks J, Pare CMB, editors. The scientific basis of drug therapy in psychiatry. Oxford: Pergamon Press; 1965. p. 63-9.
66. Roizin L, True C, Knight M. Structural effects of tranquilizers. Res Publ Ass Res Nerv Ment Dis 1959; 37: 285-324.
67. Rosenbaum AH, Niven RG, Hanson NP, Swanson DW. Tardive dyskinesia: relationship with a primary affective disorder. Dis Nerv Syst 1977; 38: 423-7.
68. Rush M, Diamond F, Alpert M. Depression as a risk factor in tardive dyskinesia. Biol Psychiatry 1982; 17: 387-92.
69. Sachdev P. The prevalence of tardive dystonia in patients with chronic schizophrenia (letter). Aust N Z J Psychiatry 1991; 25: 446-8.
70. Sachdev P. Risk factors for tardive dystonia: a case-control comparison with tardive dyskinesia. Acta Psychiatr Scand 1993a; 88: 98-103.
71. Sachdev P. Clinical characteristics of 15 patients with tardive dystonia. Am J Psychiatry 1993b; 150: 498-500.
72. Sethi KD, Hess DC, Harp RJ. Prevalence of dystonia in veterans on chronic antipsychotic therapy. Mov Disord 1990; 5: 319-21.
73. Trugman JM, Leadbetter R, Zalis ME, Burgdorf RO, Wooten GF. Treatment of severe axial tardive dystonia with clozapine: case report and hypothesis. Mov Disord 1994; 9: 441-6.
74. Van Harten PN, Matroos GE, Hoek HW, Kahn RS. The prevalence of tardive dystonia, tardive dyskinesia, parkinsonism and akathisia. The Curacao Extrapyramidal Syndromes Study: 1. Schizophr Res 1996; 19: 195-203.
75. Van Putten T, Wirshing WC, Marder SR. Tardive Meige syndrome responsive to clozapine. J Clin Psychopharmacol 1990; 10: 381-2.
76. Waddington JL, Youssef HA. Familial predisposition to both tardive dyskinesia and to cognitive dysfunction in a large psychotic sibship. Psychopharmacol Bull 1987; 23: 505-7.
77. Weiner WJ, Nausieda PA, Klawans HL. Effect of chlorpromazine on central nervous system concentrations of manganese, iron, and copper. Life Sci 1977; 20: 1181-6.
78. Weinhold P, Wegner JT, Kane JM. Familial occurrence of tardive dyskinesia. J Clin Psychiatry 1981; 42: 165-6.
79. Wojcik JD, Falk WE, Fink JS, Cole JO, Gelenberg AJ. A review of 32 cases of tardive dystonia [see comments]. Am J Psychiatry 1991; 148: 1055-9. Comment in: Am J Psychiatry 1992; 149: 1124-5.
80. Wojcik JD, Falk WE, Fink JS, Cole JO, Gelenberg AJ. A review of 32 cases of tardive dystonia [see comments]. Am J Psychiatry 1991; 148: 1055-9. Comment in: Am J Psychiatry 1992; 149: 1124-5.
81. Wolf ME, Ryan JJ, Mosnaim AD. Organicity and tardive dyskinesia. Psychosomatics 1982; 23: 475-7.
82. Yadalam KG, Korn ML, Simpson GM, Tardive dystonia: four case histories [see comments]. J Clin Psychiatry 1990; 51: 17-20. Comment in: J Clin Psychiatry 1990; 51: 348.
83. Yadalam KG, Korn ML, Simpson GM, Tardive dystonia: four case histories [see comments]. J Clin Psychiatry 1990; 51: 17-20. Comment in: J Clin Psychiatry 1990; 51: 348.
84. Yadalam KG, Korn ML, Simpson GM, Tardive dystonia: four case histories [see comments]. J Clin Psychiatry 1990; 51: 17-20. Comment in: J Clin Psychiatry 1990; 51: 348.
85. Yassa R, Ananth J. Familial tardive dyskinesia. Am J Psychiatry 1981; 138: 1618-9.
86. Yassa R, Nair V, Schwartz G. Tardive dyskinesia and the primary psychiatric diagnosis. Psychosomatics 1984; 25: 135-8.
87. Yassa R, Nair V, Dimitry R. Prevalence of tardive dystonia. Acta Psychiatr Scand 1986; 73: 629-33.
88. Yassa R, Nastase C, Dupont D, Thibeau M. Tardive dyskinesia in elderly psychiatric patients: a 5-year study. Am J Psychiatry 1992; 149: 1206-11.